Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Registry of patients in preventive cardiology clinics

Official title: Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention

Run by National Institute of Cardiovascular Diseases, Pakistan · NCT06503341 · Data updated 2026-11-12

This study is creating a registry of patients visiting preventive cardiology clinics to see how well we can identify heart health risks and work together on treatment plans.

More Cardiovascular Morbidity trials

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment10000 (estimated)
SponsorNational Institute of Cardiovascular Diseases, Pakistan
Academic / other
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedJune 17, 2021
Main results expectedJune 1, 2031
Study endsJune 1, 2041
Registry record updatedApril 13, 2026
Trial IDNCT06503341 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals attending preventive cardiology clinics seeking cardiovascular risk assessment.

Probably not a fit

Patients who refuse to give consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a registry of patients attending preventive cardiology clinics at the National Institute of Cardiovascular Diseases in Karachi, Pakistan. It focuses on assessing cardiovascular risk factors and developing effective treatment plans through shared decision-making between clinicians and patients. Data will be collected on demographic characteristics, clinical history, and risk assessments, with follow-ups to monitor outcomes. The study will utilize statistical analysis to evaluate the collected data and contribute to research publications.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of cardiovascular risk factors and improve preventive strategies for cardiovascular disease.

How similar studies have gone: Other studies have shown success in using registries for cardiovascular risk assessment, indicating that this approach is supported by existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All individuals attending the preventive cardiology clinics.

Exclusion Criteria:

* • Individuals who refused to give consent.

Where it's running

  • National Institute of Cardiovascular Diseases
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Dr Rubina Rauf — National Institute of Cardiovascular Diseases
  • Study coordinator: Dr Rubina Rauf
  • Email: drrubinarauf@gmail.com
  • Phone: +923002947117

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.